Search

This study focussed on lactic acid bacteria (LAB) screening for sourdough type II elaboration and evaluating the effects of sourdough fermentation in bread making, focussing mainly on reducing FODMAPs. After a technological performance screening, six strains (Levilactobacillus brevis, Weissella minor, Lactiplantibacillus plantarum, Leuconostoc citreum, Limosilactobacillus fermentum, and Companilactobacillus farciminis) were selected for sourdough preparation. Total titratable acidity, pH, specific volume, and enumeration of microorganisms were carried out on sourdoughs, doughs, and breads. Breads were subjected to texture profile and colour analysis, moulds and yeast enumeration, and total fructans (main group of FODMAPs) quantification. Breads produced with sourdough showed a significant reduction of fructans, greater acidity, volume, and better performance during storage when compared to fermentation using only baker's yeast. Including specific cultures as starters in sourdough reduced fructans content by >92%, thereby producing a low FODMAP bread suitable for Irritable Bowel Syndrome patients with improved nutritional and technological properties. [ABSTRACT FROM AUTHOR]

This article presents the determination of eight pyrrolizidine alkaloids (PAs) by LC-MS/MS in honeys, pollen, and Senecio brasiliensis (Asteraceae) samples, all from Santa Catarina state, Brazil. In addition, the Box-Behnken design was used to perform an optimized sample preparation on pollens and S. brasiliensis parts. Senecionine and its N-oxide, besides retrorsine N-oxide, were determined in six of the seven honeys samples. Pollen from species of the Asteraceae, Fabaceae, and Boraginaceae families were found with greater predominance in three of the seven honeys samples. In these three honeys samples were also found the highest PAs levels. In beehive pollen, flower, and leaf of S. brasiliensis, the total levels of PAs and their N-oxides reached 221, 14.1 × 104, and 14.8 × 104 mg kg−1, respectively. In honeys, these compounds are chemical contaminants and therefore undesirable when the sum exceeds 71 µg kg−1, according to EFSA. On the other hand, although PAs are naturally present in plant and pollen of some species (Senecio, Crotalaria, Bacharis, Ecchium, Mimosa scabrella, Vernonia), it is important to monitor their levels in plants but also in honeys, and other beehive products since these compounds are transferred to the final product. [ABSTRACT FROM AUTHOR]

Sugarcane yeast and brewer's yeast from ethanol production are widely used as ingredients of animal feed formulations in Brazil. To avoid the contamination of the must in ethanol production refineries, the use of antibiotics is one of the main preventive treatments. Thus, there is a risk of antibiotic residues carry over from yeast to animal feed. This unintentional addition of antibiotics can produce non-compliant feed products, due to regulatory aspects and their toxicity for animals. The results of an exploratory program to assess the occurrence of over 60 antibiotics and other pharmaceuticals in 27 sugarcane yeast and brewer's yeast samples were described. Monensin was present in seven samples with concentrations ranging from 0.47 to 263.5 mg kg−1. Other antibiotics quantitated were virginiamycin (2.25 mg kg−1) and amprolium (0.25 mg kg−1). Monensin in sugarcane yeast may represent a risk for further feeds production, especially for those products intended for sensible species such as equines and rabbits, for which monensin has toxic effects. [ABSTRACT FROM AUTHOR]

The current model of pigs and poultry production has increased stocking density and reduced downtime between lots. This scenario may favour a rise of infection and disease risk in animals. To avoid this problem, routine use of drugs has been made, intensifying the possibility of residues in animal products and antimicrobial resistance. The aim of this study was to measure carry-over and contaminants of veterinary drugs included in the feed production lines for poultry and pigs. Samples were taken from 25 production lines. LC-MS/MS was used for simultaneous analysis of 62 active ingredients. In the medicated feed, 80.4% of the samples had a concentration of active ingredients different from the stated doses. In 70% of the feed samples, there was heterogeneity in the mixture of active ingredients. In subsequent feeds, carry-over was greater than 1% of the stated dose in 63% of cases. Of the 25 analysed lines, only one showed no contamination with other active ingredients. No correlations were found between the nutritional composition of the feed and carry-over. The present study demonstrated that the current production model allows the occurrence of unwanted drugs in feed-in doses that can contaminate animal products and can select antimicrobial-resistant bacteria. [ABSTRACT FROM AUTHOR]

In many countries, ractopamine hydrochloride (RAC) is allowed to be used in animal production as a β-agonist, which is an energy repartitioning agent able to offer economic benefits such as increased muscle and decreased fat deposition, feed conversion improvement and an increase in average daily weight gain. However, some countries have banned its use and established strict traceability programmes because of pharmacological implications of β-agonist residues in meat products. In Brazil, commercial RAC is controlled (5-20 mg kg−1) and only added to pig diet during the last 28 days before slaughter. However, the control is more difficult when co-products, like meat and bone meal (MBM), which can be produced from RAC treated animals, are part of the feed composition. Therefore, a study was undertaken to evaluate the presence of RAC residue concentrations in urine and tissues of gilts (n = 40) in four dietary groups: 0%, 7%, 14% and 21% (w/w) of MBM-containing RAC (53.5 µg kg−1). The concentration of RAC residues in MBM, pig tissues and urine was determined by LC-MS. Low RAC concentrations were detected in muscle, kidney, liver and lungs (limit of detection = 0.15, 0.5, 0.5 and 1.0 µg kg−1, respectively); however, no RAC residues were quantified above the limit of quantification (0.5, 2.5, 2.5 and 2.5 µg kg−1, respectively). In urine, the RAC concentration remained below 1.35 µg L−1. These data suggest that MBM (containing 53.5 µg kg−1 RAC) added to diet up to 21% (w/w) could hamper the trade where RAC is restricted or has zero-tolerance policy. [ABSTRACT FROM AUTHOR]